Acadia Healthcare/$ACHC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Acadia Healthcare
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
- Ticker
- $ACHC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 22,000
- Headquarters
- Franklin, United States
- Website
- www.acadiahealthcare.com
ACHC Metrics
BasicAdvanced
$3.6B
-
-$12.45
0.63
-
Price and volume
Market cap
$3.6B
Beta
0.63
52-week high
$39.70
52-week low
$11.43
Average daily volume
2.1M
Financial strength
Current ratio
1.597
Quick ratio
1.313
Long term debt to equity
1.097
Total debt to equity
1.122
Interest coverage (TTM)
2.20%
Profitability
EBITDA (TTM)
535.059
Gross margin (TTM)
40.96%
Net profit margin (TTM)
-33.07%
Operating margin (TTM)
9.77%
Effective tax rate (TTM)
-3.88%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
3.48%
Return on equity (TTM)
-40.48%
Valuation
Price to revenue (TTM)
1.027
Price to book
1.74
Price to tangible book (TTM)
5.79
Price to free cash flow (TTM)
-146.823
Free cash flow yield (TTM)
-0.68%
Free cash flow per share (TTM)
-0.263
Growth
Revenue change (TTM)
4.47%
Earnings per share change (TTM)
-1,155.31%
3-year revenue growth (CAGR)
6.04%
10-year revenue growth (CAGR)
2.74%
3-year earnings per share growth (CAGR)
295.19%
10-year earnings per share growth (CAGR)
94.12%
What the Analysts think about ACHC
Analyst ratings (Buy, Hold, Sell) for Acadia Healthcare stock.
Analyst projections of the future price of Acadia Healthcare stock.
Bulls say / Bears say
Third-quarter revenue rose 5.1%, with same-facility revenue up 5.2% and acute revenue up 11.3%. Acadia raised its 2026 adjusted EBITDA forecast to $615–625 million from $590–615 million. (Acadia Healthcare)
The 16 acute facilities opened since 2023 are starting to contribute, and management expects them to add about $60 million of adjusted EBITDA in 2027 compared with 2026. Higher occupancy as these sites mature could support further earnings growth. (Acadia Healthcare)
Acadia generated $97.9 million of operating cash flow against $50.7 million of capital spending in the quarter, and repaid $63 million of debt. It also cut its full-year capital expenditure forecast, leaving more room for cash generation and debt reduction. (Acadia Healthcare, The Motley Fool)
The DOJ and SEC continue to seek information about admissions, length of stay and billing practices. Acadia says its internal review has reached no conclusions and that it cannot estimate any potential liability. (StockTitan)
A jury awarded $35 million in compensatory and $70 million in punitive damages in a case against Acadia subsidiary Fashion Valley. The subsidiary is seeking a new trial and may appeal, so the potential cost remains uncertain. (StockTitan)
Profitability weakened even as sales grew: adjusted net income fell to $54.6 million from $64.8 million a year earlier, and adjusted earnings per share dropped from $0.72 to $0.60. Operating expenses rose faster than revenue, putting pressure on earnings. (Acadia Healthcare)
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2026.
ACHC Financial Performance
Revenues and expenses
ACHC Earnings Performance
Company profitability
Upcoming events
No upcoming events
ACHC News
AllArticlesVideos
Funds containing ACHC
AllUSDEURGBP
Fund name | Fund size | $ACHC weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.31% |
iShares Ageing Population£AGES | $953M | 0.31% |
iShares Ageing Population€AGED | $903M | 0.31% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.20% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.20% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.